Apex Biotechnology Corp
TWSE:1733
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Apex Biotechnology Corp
TWSE:1733
|
TW |
Intrinsic Value
The intrinsic value of Apex Biotechnology Corp (1733) under the Base Case is 32.38 TWD per share.
Compared with the current market price of 29.6 TWD, the stock appears
Undervalued by 9% .
The intrinsic value is calculated using the DCF method. The model mostly extends the recent record: revenue grows about 0% a year over the next five years, against -1% over the last five, and net margin stays near last year's 8.4%.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Apex Biotechnology Does
Apex Biotechnology Corp makes diagnostic products used to test health markers from small blood samples. Its core products include blood glucose meters and test strips, plus related home-testing items for cholesterol, uric acid, and other common checks. The company sells these products to hospitals, clinics, pharmacies, distributors, and consumers who manage chronic conditions such as diabetes at home.
- Headquarters
- Taiwan TW
- IPO date
- Sep 17, 2001
Revenue & Expenses Breakdown
Apex Biotechnology Corp
Earnings Waterfall
Apex Biotechnology Corp
The intrinsic value for Apex Biotechnology Corp (1733) under the Base Case is 32.38 TWD.
Compared with the current market price of 29.6 TWD, the stock appears Undervalued by 9% .